Literature DB >> 14766714

The two-compartment recirculatory pharmacokinetic model--an introduction to recirculatory pharmacokinetic concepts.

R N Upton1.   

Abstract

BACKGROUND: Some limitations of traditional ("mamillary") compartmental pharmacokinetic models of anaesthetic related drugs arise from representing the blood as a central compartment. Recirculatory pharmacokinetic models overcome these limitations. It is proposed that the simplest recirculatory model has only two compartments, and that understanding the properties of this model is a useful introduction to recirculatory pharmacokinetic concepts.
METHODS: The compartments of the model are the lungs and the remainder of the body. The traditional rate constants (e.g. k12 and k21) are replaced by terms that include cardiac output. Drug infusion is into the lung compartment, and drug clearance is from the "body" compartment. The "total" drug concentrations can be thought of as the sum of the first-pass and recirculated drug concentrations at any time. Equations for both first-pass and total drug concentrations in arterial and mixed venous blood are presented. The effects of cardiac output and injection time on these concentrations were analysed.
RESULTS: The first-pass arterial concentrations were shown to make a significant contribution to the total concentrations for high-clearance drugs and/or bolus drug administration. There was an inverse relationship between these first-pass concentrations and cardiac output, and a direct relationship with bolus injection rate. Thus, the total arterial concentrations are affected by these factors in these circumstances.
CONCLUSIONS: The two-compartment recirculatory model is the simplest tool available for elaborating recirculatory pharmacokinetic concepts. The recirculatory approach may provide a conceptual framework of drug disposition that better matches the clinical experience of anaesthetists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766714     DOI: 10.1093/bja/aeh089

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

2.  Comparison of distributed and compartmental models of drug disposition: assessment of tissue uptake kinetics.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-08-17       Impact factor: 2.745

3.  A physiologically-based recirculatory meta-model for nasal fentanyl in man.

Authors:  Richard N Upton; David J R Foster; Lona L Christrup; Ola Dale; Kristin Moksnes; Lars Popper
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-19       Impact factor: 2.745

4.  Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; Richard N Upton; David J R Foster
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-17       Impact factor: 2.745

5.  Computer simulated modeling of healthy and diseased right ventricular and pulmonary circulation.

Authors:  Jody Chou; Joseph B Rinehart
Journal:  J Clin Monit Comput       Date:  2018-01-12       Impact factor: 2.502

6.  Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of drugs - method development and application to magnesium in sheep.

Authors:  Richard N Upton; Guy L Ludbrook
Journal:  BMC Pharmacol       Date:  2005-03-10

7.  Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations.

Authors:  Lars Ole Schwen; Arne Schenk; Clemens Kreutz; Jens Timmer; María Matilde Bartolomé Rodríguez; Lars Kuepfer; Tobias Preusser
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.